Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

38.54 +0.14 (+0.36%)
Official Closing Price Updated: 7:00 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,996,429
Open 38.69
Bid (Size) 35.00 (1)
Ask (Size) 39.00 (1)
Prev. Close 38.40
Today's Range 38.47 - 38.85
52wk Range 31.71 - 45.80
Shares Outstanding 5,385,189,617
Dividend Yield 4.16%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GSK To Buy Phase-3 Ready Liver Disease Drug For Up To $2 Billion
GSK acquires Boston Pharmaceuticals' efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD. 
Via Benzinga
iTeos Stock Soars Despite Trial Setback On Liquidation Buzz And Solid Cash Pile
iTeos ends belrestotug program with GSK after Phase 2 trial fails to meet key survival goals; company explores strategic options to boost shareholder value. 
Via Benzinga

Performance

YTD
+13.5%
+13.5%
1 Month
+5.7%
+5.7%
3 Month
+5.5%
+5.5%
6 Month
+15.6%
+15.6%
1 Year
-13.3%
-13.3%

More News

Read More
Trump’s ‘Most Favored Nation’ Drug Plan Likely To Face Pushback, JP Morgan Analysts Say
Via Stocktwits
Topics ETFs Government Stocks
Exposures Political US Equities
GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis
From GSK plc
Via Business Wire
Earnings Scheduled For April 30, 2025
Via Benzinga
Britain's GSK Asserts It Is 'Well Positioned' To Mitigate Potential Tariffs After Strong Q1 Cancer And HIV Drug Sales
Via Benzinga
GSK Jumps On Solid Earnings, Says It's 'Well Positioned' To Navigate Tariffs
Via Investor's Business Daily
Topics Economy Government World Trade
Exposures Political Supply Chain Tariff
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
Via Benzinga
UK Becomes First Country To Authorize Blenrep In Two Combo Regimens
Via Benzinga
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
From Alector, Inc.
Via GlobeNewswire
AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices
From GSK plc
Via Business Wire
GSK’s 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices
From GSK plc
Via Business Wire
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Via Benzinga
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025
From GSK plc
Via Business Wire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Faruqi & Faruqi Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK
From Faruqi & Faruqi LLP
Via GlobeNewswire
A Look Into GSK Inc's Price Over Earnings
Via Benzinga
Deadline Soon: GSK plc. (GSK) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From Law Offices of Frank R. Cruz
Via Business Wire
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops
Via Benzinga
GSK Deadline: Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
From Pomerantz LLP
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
From Pomerantz LLP
Via GlobeNewswire
Looking Into GSK's Recent Short Interest
Via Benzinga
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
Via Benzinga
Exposures Product Safety

Frequently Asked Questions

Is GSK plc American Depositary Shares (Each representing two Ordinary Shares) publicly traded?
Yes, GSK plc American Depositary Shares (Each representing two Ordinary Shares) is publicly traded.
What exchange does GSK plc American Depositary Shares (Each representing two Ordinary Shares) trade on?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) trades on the New York Stock Exchange
What is the ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares) is GSK on the New York Stock Exchange
What is the current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 38.54
When was GSK plc American Depositary Shares (Each representing two Ordinary Shares) last traded?
The last trade of GSK plc American Depositary Shares (Each representing two Ordinary Shares) was at 05/21/25 07:00 PM ET
What is the market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?
The market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 207.55B
How many shares of GSK plc American Depositary Shares (Each representing two Ordinary Shares) are outstanding?
GSK plc American Depositary Shares (Each representing two Ordinary Shares) has 208B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.